Why the Same Cannabis Smoke Exposure Produced Different Blood and Brain Profiles in Mice

Standardized cannabis smoke exposure did not yield identical cannabinoid profiles across mouse groups or biological compartments. A pharmacokinetic study shows why experimental dose delivery and measured exposure must remain separate.

What was sampled?

Gazarov and colleagues exposed mice to cannabis smoke, then measured THC, 11-hydroxy-THC, and THC-COOH in plasma and brain homogenates. Experiments examined time course, sex, age, strain, and different smoke-exposure amounts.

The number of cigarettes burned described the exposure system. It was not a direct measurement of how many milligrams entered each animal’s circulation.

Some differences appeared only in particular endpoints

Observed peak times differed between male and female mice and between plasma and brain. Females had higher plasma THC-COOH across the experiments. Certain strain differences appeared in brain THC even though corresponding plasma THC differences were absent at the sampled times.

Reducing the smoke exposure changed plasma THC-COOH significantly, but did not produce significant differences in every parent-THC or hydroxylated-metabolite endpoint. Dose-response claims therefore require the exact analyte and sampling schedule.

What this contributes to human interpretation

The study improves an inhalation model that differs from injected THC experiments. It does not establish human sex-specific impairment thresholds or a blood-to-brain conversion formula.

Brain homogenate, plasma, and whole blood are distinct matrices. A difference in one cannot be silently assigned to another. For an expert opinion, specify the route, biological compartment, collection interval, and outcome before using animal kinetics to support a human inference.

The design sampled plasma and brain at defined intervals after smoke exposure. Absence of a significant age or strain difference in plasma THC did not exclude a strain difference in brain THC. This is a concrete reason to avoid treating a result in circulating plasma as a complete description of exposure throughout the nervous system.

Related reading: limits of converting THC concentrations into functional conclusions.

Primary research

Emely A. Gazarov; Sabrina Zequeira; Alexandria S. Senetra; John Howard; Abhisheak Sharma; Christopher R. McCurdy; Jada Lewis; Jennifer L. Bizon; Barry Setlow. Pharmacokinetics of delta-9-tetrahydrocannabinol following acute cannabis smoke exposure in mice; effects of sex, age, and strain. Frontiers in Pharmacology (2023). DOI: 10.3389/fphar.2023.1227220.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Plant Raman Testing for THC and CBD: Why Sampling the Right Tissue Matters

Where a Raman instrument samples a cannabis plant can determine whether it obtains useful cannabinoid information. A 42-plant study found informative THC- and CBD-related signals in glandular-trichome-rich regions, while other leaf and stem regions did not provide the same information. Why the wavelength and tissue mattered Porcu and colleagues investigated…

Spread the love

Read Article: Plant Raman Testing for THC and CBD: Why Sampling the Right Tissue Matters

Nabiximols and Urine Screening: A Dose Correlation Is Not an Impairment Measurement

A urine cannabinoid screen can correlate with a prescribed nabiximols dose without measuring impairment. In a small multiple-sclerosis study, the relationship concerned ongoing treatment exposure and laboratory response. It did not establish an acute driving-risk threshold or a way to calculate an individual’s exact dose from one specimen. Who was…

Spread the love

Read Article: Nabiximols and Urine Screening: A Dose Correlation Is Not an Impairment Measurement

Why 98.7% Fingerprint THC Agreement Needs Its Underlying Counts

A fingerprint THC screen achieved 98.7% agreement with laboratory fingerprint testing in 75 postmortem cases. The underlying counts were 73 true negatives, one true positive and one false positive. Those numbers convey much more about the evidence than the headline percentage alone. What “accuracy” referred to Hudson and colleagues evaluated…

Spread the love

Read Article: Why 98.7% Fingerprint THC Agreement Needs Its Underlying Counts

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us